Abstract
A set of novel fragment-like catechol derivatives were identified as EphA2 inhibitors and were further profiled against a panel of 19 tyrosine kinases. In addition to EphA2, the recovered hits were active against EGFR, FGFR1, FGFR2, Abl and PDGFR-a, and according to molecular modelling studies catechol moiety was capable of forming two or more correlated hydrogen bonds with the kinase hinge region, suggesting prospects of its further optimization as an EphA2 inhibitor.
References
1.
van der Geer P., Hunter T., Lindberg R.A.
Annual Review of Cell Biology,
1994
2.
Lindberg R.A., Hunter T.
Molecular and Cellular Biology,
1990
3.
Maru Y., Hirai H., Yoshida M.C., Takaku F.
Molecular and Cellular Biology,
1988
4.
Pandey A., Lazar D.F., Saltiel A.R., Dixit V.M.
Journal of Biological Chemistry,
1994
5.
10.1016/j.mencom.2010.09.007_bib0025
Brantley-Sieders
J. Cell Sci.,
2003
6.
10.1016/j.mencom.2010.09.007_bib0030
Dong-Ping
Int. J. Oncol.,
2007
7.
Mologni L., Sala E., Riva B., Cesaro L., Cazzaniga S., Redaelli S., Marin O., Pasquato N., Donella-Deana A., Gambacorti-Passerini C.
Protein Expression and Purification,
2005
8.
Stroganov O.V., Novikov F.N., Stroylov V.S., Kulkov V., Chilov G.G.
Journal of Chemical Information and Modeling,
2008
9.
Korkina L., Scordo M., Deeva I., Cesareo E., De Luca C.
Current Drug Metabolism,
2009
10.
Ishii T., Ishikawa M., Miyoshi N., Yasunaga M., Akagawa M., Uchida K., Nakamura Y.
Chemical Research in Toxicology,
2009
11.
Kohyama N., Nagata T., Fujimoto S., Sekiya K.
Bioscience, Biotechnology and Biochemistry,
1997